Welcome to the latest of our Eberhard F. Mammen award announcements. As noted previously,[1]
[2]
[3] Thieme, the publisher of Seminars in Thrombosis & Hemostasis, has created the “Eberhard F. Mammen Excellence in Thrombosis and Hemostasis Awards” in honor of Eberhard F. Mammen ([Fig. 1]), and in recognition of his contribution to this field and to the journal that he both founded and steered for over three decades. These awards began in 2009, under two categories, “Most Popular Article Award” and “Young Investigator Award.” Current details and conditions of the award can be summarized as follows:
Fig. 1 Eberhard F Mammen (1930–2008).
Most Popular Article Awards: Awarded to the authors of the most popular articles published in Seminars in Thrombosis & Hemostasis. The awards are determined by the Editor in Chief on the basis of user statistics from Thieme e-Journals from the preceding 2 years. Prefaces, Errata, Letters to the Editor, Editorials, and previous award winning articles are excluded from further consideration of these awards, which currently comprise two categories—one for “Open Access” articles, and another for a “General Category.” There are two major cash prizes of US$1,000 for each category. In addition, winners of the “General Category” awards are granted “open access” status for these articles thereafter.
Young Investigator Awards: Best presentation or meeting abstract by a young investigator—as presented or delivered to an international or large regional meeting on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr. Mammen. Up to six cash prizes of US$1,000 in any year. There are some additional considerations and conditions for the award, and awardees are expected to prepare a review or other article related to the topic of their presentation for publication in Seminars in Thrombosis & Hemostasis.
Further details of the awards and the award winners are posted online (http://www.thieme.com/sth), and previous award winner announcements are also available in print.[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
It is therefore with great pleasure that we would like to announce the latest winners of the 2017 Eberhard F. Mammen Awards for the most popular articles from Seminars in Thrombosis & Hemostasis for the period of 2015–2016 inclusive. We will be announcing the Young Investigator Awards related to meetings held in the recent past at a forthcoming opportunity.
References
1
Favaloro EJ.
Editorial. Welcome to a special issue of Seminars in Thrombosis & Hemostasis—the closing issue for 2008. Semin Thromb Hemost 2008; 34: 693-696
16
Favaloro EJ,
Lippi G.
Laboratory testing in the era of direct or non-vitamin K antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors. Semin Thromb Hemost 2015; 41 (02) 208-227
20
Raskob GE,
Angchaisuksiri P,
Blanco AN.
, et al; ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. Semin Thromb Hemost 2014; 40 (07) 724-735
24
Zolfaghari S,
Harenberg J,
Froelich L,
Wehling M,
Weiss C.
Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy. Semin Thromb Hemost 2014; 40 (01) 121-128
25
Harenberg J,
Du S,
Krämer S,
Weiss C,
Krämer R,
Wehling M.
Patients' serum and urine as easily accessible samples for the measurement of non-vitamin K antagonist oral anticoagulants. Semin Thromb Hemost 2015; 41 (02) 228-236
31
Senoo K,
Lip GY.
Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation. Semin Thromb Hemost 2015; 41 (02) 146-153
32
Mallett SV.
Clinical utility of viscoelastic tests of coagulation (TEG/ROTEM) in patients with liver disease and during liver transplantation. Semin Thromb Hemost 2015; 41 (05) 527-537
33
McMahon BJ,
Kwaan HC.
The new or non-vitamin K antagonist oral anticoagulants: what have we learned since their debut. Semin Thromb Hemost 2015; 41 (02) 188-194